Tyra Biosciences, Inc. (NASDAQ: TYRA) is making waves in the healthcare sector, particularly in the biotechnology industry, as it targets a potentially massive 196.39% upside according to analyst ratings. With..
AnaptysBio, Inc. (NASDAQ: ANAB), a clinical-stage biotechnology company based in San Diego, stands out in the healthcare sector with a promising potential upside of 101.26%. Specializing in the development of..
Owens & Minor, Inc. (NYSE: OMI), a prominent player in the medical distribution industry, is capturing the attention of investors with its significant potential upside. With a market capitalization of..
Orthofix Medical Inc. (NASDAQ: OFIX), a leading player in the medical devices sector, is currently trading at $10.71. With a market capitalization of $419.63 million, this healthcare company specializes in..
Investors seeking opportunities in the biotechnology sector might find uniQure N.V. (NASDAQ: QURE) an intriguing prospect. With its focus on developing gene therapy treatments for rare and severe diseases, the..
Semler Scientific, Inc. (NASDAQ: SMLR) stands at the intersection of healthcare innovation and the medical devices industry, offering investors a unique glimpse into the rapidly evolving landscape of clinical technology..
Definitive Healthcare Corp. (NASDAQ: DH), a prominent player in the health information services sector, offers a unique SaaS healthcare commercial intelligence platform. With a market capitalization of $382.14 million, this..
Theravance Biopharma, Inc. (NASDAQ: TBPH), a key player in the biotechnology sector, has been capturing the attention of investors with its promising pipeline and strategic collaborations. With a market capitalization..
Investors looking to capitalize on high-growth opportunities in the healthcare sector might want to turn their attention to AxoGen, Inc. (NASDAQ: AXGN). With a market capitalization of $491.88 million, this..
Community Health Systems, Inc. (NYSE: CYH), a prominent player in the healthcare sector, is navigating a complex landscape marked by both challenges and opportunities. As a key operator of general..
In the rapidly evolving landscape of biotechnology, Upstream Bio, Inc. (NASDAQ: UPB) is attracting considerable attention from investors, particularly due to its staggering 358.60% potential upside. With its focus on..
Kura Oncology, Inc. (NASDAQ: KURA) has captured the attention of investors in the biotechnology sector, with its current stock price offering a tantalizing potential upside of 294.47%, according to analyst..
Investors looking for opportunities in the healthcare sector might find CorMedix Inc. (NASDAQ: CRMD) an intriguing prospect. This biopharmaceutical company, with a market cap of approximately $893.93 million, specializes in..
LENZ Therapeutics, Inc. (NASDAQ: LENZ) is making waves in the biotechnology sector, particularly for investors looking to capitalize on its promising potential upside. As a biopharmaceutical company, LENZ focuses on..
Butterfly Network, Inc. (NYSE: BFLY) is catching the attention of investors with a compelling potential upside of 77.31%, according to recent analyst ratings. Operating in the healthcare sector, specifically within..
STAAR Surgical Company (NASDAQ: STAA), a prominent player in the healthcare sector specializing in medical instruments and supplies, is currently capturing investor attention for its strategic market position and potential..
Evolus, Inc. (NASDAQ: EOLS) is capturing attention in the investment community with a potential upside of 142.01%, making it a stock worth a closer look. This performance beauty company, known..
Zymeworks Inc. (NASDAQ: ZYME) is making waves in the biotechnology sector with its cutting-edge therapeutic platforms aimed at combating cancer and autoimmune diseases. With a promising potential upside of 77.7%,..
OrthoPediatrics Corp. (NASDAQ: KIDS) is a prominent player in the healthcare sector, specializing in the medical devices industry. With a focus on pediatric orthopedics, the company is well-positioned within a..
Spyre Therapeutics, Inc. (NASDAQ: SYRE) is capturing the attention of investors with its promising pipeline in the biotechnology sector, particularly focusing on innovative treatments for inflammatory bowel disease (IBD). With..
